Evidence map›Paper›PMID 31967131›Full record

ReviewPhysical chemistry chemical physics : PCCP2020

High throughput sequencing of in vitro selections of mRNA-displayed peptides: data analysis and applications.

Celia Blanco, Samuel Verbanic, Burckhard Seelig, Irene A Chen

Abstract readReview
In one paragraph

Review in Physical chemistry chemical physics : PCCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Cell-Free Display Techniques for Protein Evolution.Advances in biochemical engineering/biotechnology · 2023
    Article
  6. Article
  7. Research on Cancer Molecular Typing Based on High-Throughput Sequencing Technology.Computational and mathematical methods in medicine · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Celia BlancoDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA 93106, USA. blanco@ucsb.edu.
Samuel Verbanic
Burckhard Seelig
Irene A Chen

Funding

Understanding how bacteriophages affect wound ecologies and developing new tools to harness bacteria-phage interactionsDP2GM123457 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI CHEN, IRENE ANN · 2016 to 2016
$2.3M
Developing a synthetic evolution approach to create de novo enzymesR01GM108703 · NIGMS · UNIVERSITY OF MINNESOTA · PI SEELIG, BURCKHARD · 2014 to 2017
$1.1M
Developing methods to engineer therapeutic proteasesR21AI113406 · NIAID · UNIVERSITY OF MINNESOTA · PI SEELIG, BURCKHARD · 2015 to 2016
$401k
NASA NNX14AK29GNASA NNX16AJ32GNIAID NIH HHS R21 AI113406NIGMS NIH HHS DP2 GM123457NIGMS NIH HHS R01 GM108703
6 · The paper itself

Abstract

In vitro selection using mRNA display is currently a widely used method to isolate functional peptides with desired properties. The analysis of high throughput sequencing (HTS) data from in vitro evolution experiments has proven to be a powerful technique but only recently has it been applied to mRNA display selections. In this Perspective, we introduce aspects of mRNA display and HTS that may be of interest to physical chemists. We highlight the potential of HTS to analyze in vitro selections of peptides and review recent advances in the application of HTS analysis to mRNA display experiments. We discuss some possible issues involved with HTS analysis and summarize some strategies to alleviate them. Finally, the potential for future impact of advancing HTS analysis on mRNA display experiments is discussed.

Indexed as

High-Throughput Nucleotide SequencingGene Expression ProfilingIn Vitro TechniquesRNA, MessengerSequence Analysis, ProteinRNA, Messenger

Identifiers

PMID31967131
PMCPMC8219182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.